Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prevalence of Sarcopenia-Promoting Medicines in Patients With Sarcopenia and Falls
Sponsor: Medway NHS Foundation Trust
Summary
Sarcopenia, characterised by the loss of muscle mass and function, is a common condition among the elderly and is often associated with increased risk of falls. Certain medications, such as glucocorticoids, statins, and some antipsychotics, may exacerbate sarcopenia, leading to a higher incidence of falls. This study aims to explore the prevalence of such medicines in patients diagnosed with sarcopenia who have experienced falls. Understanding the impact of these medications on sarcopenia and fall risk can inform clinical guidelines and improve patient outcomes.
Official title: Exploratory Study on the Prevalence of Sarcopenia-Promoting Medicines in Patients With Sarcopenia and Falls
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
OBSERVATIONAL
Enrollment
323
Start Date
2025-09
Completion Date
2026-07
Last Updated
2025-08-22
Healthy Volunteers
No
Conditions
Interventions
Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls (SARC-F) questionnaire
Self-administered screening tool for sarcopenia
Hand grip strength
Used to assess sarcopenia
Timed Up and Go test
Screening test for falls in elderly
Gait speed
Assessment to check for functional mobility and risk of falls.
Clinical Frailty Scale (CFS)
Used to assess level of frailty.
Locations (1)
Medway NHS Foundation Trust
Gillingham, Kent, United Kingdom